BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, March 16, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 24, 2009
View Archived Issues
New mTOR kinase inhibtors reported in recent AstraZeneca patents
Read More
New deuterium-enriched eszopiclone analogues reported for insomnia in recent Protia patent
Read More
Novel CRF receptor antagonists for depression and other disorders discovered by Taisho researchers
Read More
sanofi-aventis researchers report new coagulation factor VIIa inhibitors
Read More
NeuroSearch claims novel potassium BK channel modulators for treating Alzheimer's disease
Read More
MAPKAP-K2 inhibitors from Wyeth active against rheumatoid arthritis, other inflammatory conditions
Read More
Recent AstraZeneca patent imparts new bacterial DNA gyrase inhibitors
Read More
New cannabinoid CB2 receptor ligands in development as analgesic agents at Abbott
Read More
AstraZeneca launches Seroquel XR for bipolar depression
Read More
CytRx initiates phase II/III arimoclomol trial in familial ALS
Read More
Endo completes tender offer for shares of Indevus
Read More
European Commission approves Efient for acute coronary syndrome
Read More
GeoVax starts injections in phase IIa human HIV/AIDS vaccine trial
Read More
GTx initiates phase I trial for GTx-758 in advanced prostate cancer
Read More
A-804598 and its tritiated radioligand specifically and potently inhibit P2X7 receptors
Read More
Phase III Cyzact results fail to meet primary endpoint
Read More
Desmoteplase shows no beneficial effects in acute ischemic stroke in phase III clinical trial
Read More
JN-403 displays procognitive, antinociceptive, antiepileptic and anxiolytic effects in rodents
Read More
Cell Therapeutics sells 50% ownership interest in Zevalin joint venture to Spectrum
Read More
Neuralstem puts clinical hold on spinal cord stem cell trial to treat ALS
Read More
Actelion acquires thermostable formulation of epoprostenol sodium from GeneraMedix
Read More
Schering-Plough and WHO sign agreement for influenza vaccine manufacturing technology
Read More
ALK-Abello and Novozymes sign agreement for recombinant allergens
Read More
Bavarian Nordic presents positive updated data on phase I/II studies of MVA-BN-HER2
Read More
